Fawzi Benzaghou has built his career around developing treatments for some of the most challenging conditions in medicine.
As Chief Medical Officer at Parabilis Medicines, he leads clinical and regulatory strategy for therapies targeting both rare and common cancers.
Before this, he served as Senior Vice President and Global Head of Oncology R&D at Ipsen. In that role, he contributed to multiple regulatory approvals across cancer indications.
Fawzi also trained and practiced as a pediatric surgeon at Necker Children’s Hospital in Paris.
This clinical background informs how he approaches drug development. It keeps patient outcomes central to decision-making.
His work connects scientific research with practical application in healthcare, focusing on how new therapies can reach patients effectively. more accessible medicine.
Found him interesting? Connect with Fawzi on LinkedIn.
